Standing Together for a Greater Cause In a remarkable display of unity, Dr. Sujuan B., CEO of the Asian Fund for Cancer Research (AFCR), and Dr. Kwok Leung, CFO, proudly stood shoulder to shoulder with the Global Coalition for Adaptive Research (GCAR), esteemed partners, brave patients, and dedicated advocates…...
AFCR’s South Pole Trek for Cancer Research
Join AFCR Chairman, Lance Kawaguchi, on an extraordinary journey to the South Pole this December as he takes on the ultimate challenge of walking 14,871 steps each day, symbolizing the 14,871 lives lost to cancer in Hong Kong to raise awareness and vital funds for cancer research. This enduring trek…...
AFCR Launches the Double Your Impact Campaign in Partnership with Hugill & Ip
FOR IMMEDIATE RELEASE: 1 February 2023 CONTACTS: Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: [email protected] World Cancer Day – held every 4 February – is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action, UICC partners…...
Be a Spark of Hope for Cancer Patients – Renew Your Support Today!
As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult battle. Your contribution will make a real difference…...
AFCR Annual Reception: A Community Effort to Find Cures for Cancer
On December 15, 2022, the Asian Fund for Cancer Research (AFCR) held its annual reception for community support of cancer research in Hong Kong. The event was a great success, thanks to the support of generous donors, attendees, and inspiring speakers who shared their thoughts on the importance of cancer…...
94% of the U.S. population has been infected with the new coronavirus
By November 10, 2022, 94% (95% CrI, 79%-99%) of the US population were estimated to have been infected by SARS-CoV-2 at least once. Combined with vaccination, 97% (95%-99%) were estimated to have some prior immunological exposure to SARS-CoV-2. Between December 1, 2021 and November 10, 2022, protection against a new…...
Impact Investment: Interview with Arbele
The Asian Fund for Cancer Research aims to accelerate cancer research and technologies through international collaborations. As part of our mission, AFCR has created the BRACE Award Venture Competition to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into…...
Promising Cancer Research Programs Need Your Help!
I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects. Generous friends like you will help determine which investigations will be…...
AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!
Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent great progress! With your previous support and funding, the drug indicated for the potential treatment…...
